Table of Contents
Global Active Pharmaceutical Ingredient Market Professional Survey Report 2021
1 Industry Overview of Active Pharmaceutical Ingredient
1.1 Definition and Specifications of Active Pharmaceutical Ingredient
1.1.1 Definition of Active Pharmaceutical Ingredient
1.1.2 Specifications of Active Pharmaceutical Ingredient
1.2 Classification of Active Pharmaceutical Ingredient
1.2.1 Synthetic API
1.2.2 Biotech API
1.2.3 Other
1.3 Applications of Active Pharmaceutical Ingredient
1.3.1 Chemical
1.3.2 Deodorant
1.3.3 Dailylife
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient
2.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient
2.4 Industry Chain Structure of Active Pharmaceutical Ingredient
3 Technical Data and Manufacturing Plants Analysis of Active Pharmaceutical Ingredient
3.1 Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient Major Manufacturers in 2020
3.2 Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient Major Manufacturers in 2020
3.3 R&D Status and Technology Source of Global Active Pharmaceutical Ingredient Major Manufacturers in 2020
3.4 Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient Major Manufacturers in 2020
4 Global Active Pharmaceutical Ingredient Overall Market Overview
4.1 2016 - 2021E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2016 - 2021E Global Active Pharmaceutical Ingredient Capacity and Growth Rate Analysis
4.2.2 2020 Active Pharmaceutical Ingredient Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2016 - 2021E Global Active Pharmaceutical Ingredient Sales and Growth Rate Analysis
4.3.2 2020 Active Pharmaceutical Ingredient Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2016 - 2021E Global Active Pharmaceutical Ingredient Sales Price
4.4.2 2020 Active Pharmaceutical Ingredient Sales Price Analysis (Company Segment)
5 Active Pharmaceutical Ingredient Regional Market Analysis
5.1 North America Active Pharmaceutical Ingredient Market Analysis
5.1.1 North America Active Pharmaceutical Ingredient Market Overview
5.1.2 North America 2016 - 2021E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2016 - 2021E Active Pharmaceutical Ingredient Sales Price Analysis
5.1.4 North America 2020 Active Pharmaceutical Ingredient Market Share Analysis
5.2 Europe Active Pharmaceutical Ingredient Market Analysis
5.2.1 Europe Active Pharmaceutical Ingredient Market Overview
5.2.2 Europe 2016 - 2021E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2016 - 2021E Active Pharmaceutical Ingredient Sales Price Analysis
5.2.4 Europe 2020 Active Pharmaceutical Ingredient Market Share Analysis
5.3 China Active Pharmaceutical Ingredient Market Analysis
5.3.1 China Active Pharmaceutical Ingredient Market Overview
5.3.2 China 2016 - 2021E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2016 - 2021E Active Pharmaceutical Ingredient Sales Price Analysis
5.3.4 China 2020 Active Pharmaceutical Ingredient Market Share Analysis
5.4 Japan Active Pharmaceutical Ingredient Market Analysis
5.4.1 Japan Active Pharmaceutical Ingredient Market Overview
5.4.2 Japan 2016 - 2021E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2016 - 2021E Active Pharmaceutical Ingredient Sales Price Analysis
5.4.4 Japan 2020 Active Pharmaceutical Ingredient Market Share Analysis
5.5 Southeast Asia Active Pharmaceutical Ingredient Market Analysis
5.5.1 Southeast Asia Active Pharmaceutical Ingredient Market Overview
5.5.2 Southeast Asia 2016 - 2021E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2016 - 2021E Active Pharmaceutical Ingredient Sales Price Analysis
5.5.4 Southeast Asia 2020 Active Pharmaceutical Ingredient Market Share Analysis
5.6 India Active Pharmaceutical Ingredient Market Analysis
5.6.1 India Active Pharmaceutical Ingredient Market Overview
5.6.2 India 2016 - 2021E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2016 - 2021E Active Pharmaceutical Ingredient Sales Price Analysis
5.6.4 India 2020 Active Pharmaceutical Ingredient Market Share Analysis
6 Global 2016 - 2021E Active Pharmaceutical Ingredient Segment Market Analysis (by Type)
6.1 Global 2016 - 2021E Active Pharmaceutical Ingredient Sales by Type
6.2 Different Types of Active Pharmaceutical Ingredient Product Interview Price Analysis
6.3 Different Types of Active Pharmaceutical Ingredient Product Driving Factors Analysis
6.3.1 Synthetic API of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
6.3.2 Biotech API of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
6.3.3 Other of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7 Global 2016 - 2021E Active Pharmaceutical Ingredient Segment Market Analysis (by Application)
7.1 Global 2016 - 2021E Active Pharmaceutical Ingredient Consumption by Application
7.2 Different Application of Active Pharmaceutical Ingredient Product Interview Price Analysis
7.3 Different Application of Active Pharmaceutical Ingredient Product Driving Factors Analysis
7.3.1 Chemical of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.2 Deodorant of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.3 Dailylife of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Active Pharmaceutical Ingredient
8.1 Teva
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Teva 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.1.4 Teva 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.2 Novartis
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Novartis 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.2.4 Novartis 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.3 Pfizer
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Pfizer 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.3.4 Pfizer 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.4 Johnson & Johnson
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Johnson & Johnson 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.4.4 Johnson & Johnson 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.5 Mylan
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Mylan 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.5.4 Mylan 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.6 North China Pharmaceutical Group
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 North China Pharmaceutical Group 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.6.4 North China Pharmaceutical Group 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.7 Dr. Reddys Laboratories
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Dr. Reddys Laboratories 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.7.4 Dr. Reddys Laboratories 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.8 Roche
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Roche 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.8.4 Roche 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.9 Aurobindo pharma
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Aurobindo pharma 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.9.4 Aurobindo pharma 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.10 Sun Pharmaceutical Industries
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Sun Pharmaceutical Industries 2020 Active Pharmaceutical Ingredient Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.10.4 Sun Pharmaceutical Industries 2020 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.11 Boehringer Ingelheim GmbH
8.12 Bayer
8.13 BASF
8.14 DSM
8.15 Zhejiang Medicine
8.16 Biocon
8.17 Johnson Matthey
8.18 Hisun Pharmacy
8.19 Cambrex
8.20 Shandong Xinhua Pharmaceutical
8.21 Lonza group
8.22 Huahai Pharmaceutical
8.23 Haerbin Pharmaceutical Group
8.24 Cipla
8.25 Tian Yao
8.26 Lupin
8.27 North East Pharmaceutical
8.28 Albemarle
8.29 Shandong Lukang Pharmaceutical
8.30 JiangsuHengrui Medicine
9 Development Trend of Analysis of Active Pharmaceutical Ingredient Market
9.1 Global Active Pharmaceutical Ingredient Market Trend Analysis
9.1.1 Global 2021 - 2027 Active Pharmaceutical Ingredient Market Size (Volume and Value) Forecast
9.1.2 Global 2021 - 2027 Active Pharmaceutical Ingredient Sales Price Forecast
9.2 Active Pharmaceutical Ingredient Regional Market Trend
9.2.1 North America 2021 - 2027 Active Pharmaceutical Ingredient Consumption Forecast
9.2.2 Europe 2021 - 2027 Active Pharmaceutical Ingredient Consumption Forecast
9.2.3 China 2021 - 2027 Active Pharmaceutical Ingredient Consumption Forecast
9.2.4 Japan 2021 - 2027 Active Pharmaceutical Ingredient Consumption Forecast
9.2.5 Southeast Asia 2021 - 2027 Active Pharmaceutical Ingredient Consumption Forecast
9.2.6 India 2021 - 2027 Active Pharmaceutical Ingredient Consumption Forecast
9.3 Active Pharmaceutical Ingredient Market Trend (Product Type)
9.4 Active Pharmaceutical Ingredient Market Trend (Application)
10 Active Pharmaceutical Ingredient Marketing Type Analysis
10.1 Active Pharmaceutical Ingredient Regional Marketing Type Analysis
10.2 Active Pharmaceutical Ingredient International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Active Pharmaceutical Ingredient by Region
10.4 Active Pharmaceutical Ingredient Supply Chain Analysis
11 Consumers Analysis of Active Pharmaceutical Ingredient
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Active Pharmaceutical Ingredient Market Professional Survey Report 2020
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Active Pharmaceutical Ingredient
Table Product Specifications of Active Pharmaceutical Ingredient
Table Classification of Active Pharmaceutical Ingredient
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Type in 2020
Figure Synthetic API Picture
Table Major Manufacturers of Synthetic API
Figure Biotech API Picture
Table Major Manufacturers of Biotech API
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Active Pharmaceutical Ingredient
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Application in 2020
Figure Chemical Examples
Table Major Consumers in Chemical
Figure Deodorant Examples
Table Major Consumers in Deodorant
Figure Dailylife Examples
Table Major Consumers in Dailylife
Figure Market Share of Active Pharmaceutical Ingredient by Regions
Figure North America Active Pharmaceutical Ingredient Market Size (Million USD) (2016 - 2027)
Figure Europe Active Pharmaceutical Ingredient Market Size (Million USD) (2016 - 2027)
Figure China Active Pharmaceutical Ingredient Market Size (Million USD) (2016 - 2027)
Figure Japan Active Pharmaceutical Ingredient Market Size (Million USD) (2016 - 2027)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Size (Million USD) (2016 - 2027)
Figure India Active Pharmaceutical Ingredient Market Size (Million USD) (2016 - 2027)
Table Active Pharmaceutical Ingredient Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient in 2020
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredient
Figure Industry Chain Structure of Active Pharmaceutical Ingredient
Table Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient Major Manufacturers in 2020
Table Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient Major Manufacturers in 2020
Table R&D Status and Technology Source of Global Active Pharmaceutical Ingredient Major Manufacturers in 2020
Table Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient Major Manufacturers in 2020
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Active Pharmaceutical Ingredient 2016 - 2021E
Figure Global 2016 - 2021E Active Pharmaceutical Ingredient Market Size (Volume) and Growth Rate
Figure Global 2016 - 2021E Active Pharmaceutical Ingredient Market Size (Value) and Growth Rate
Table 2016 - 2021E Global Active Pharmaceutical Ingredient Capacity and Growth Rate
Table 2020 Global Active Pharmaceutical Ingredient Capacity (K MT) List (Company Segment)
Table 2016 - 2021E Global Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate
Table 2020 Global Active Pharmaceutical Ingredient Sales (K MT) List (Company Segment)
Table 2016 - 2021E Global Active Pharmaceutical Ingredient Sales Price (USD/MT)
Table 2020 Global Active Pharmaceutical Ingredient Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2016 - 2021E
Figure North America 2016 - 2021E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure North America 2020 Active Pharmaceutical Ingredient Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2016 - 2021E
Figure Europe 2016 - 2021E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure Europe 2020 Active Pharmaceutical Ingredient Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2016 - 2021E
Figure China 2016 - 2021E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure China 2020 Active Pharmaceutical Ingredient Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2016 - 2021E
Figure Japan 2016 - 2021E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure Japan 2020 Active Pharmaceutical Ingredient Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2016 - 2021E
Figure Southeast Asia 2016 - 2021E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure Southeast Asia 2020 Active Pharmaceutical Ingredient Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2016 - 2021E
Figure India 2016 - 2021E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure India 2020 Active Pharmaceutical Ingredient Sales Market Share
Table Global 2016 - 2021E Active Pharmaceutical Ingredient Sales (K MT) by Type
Table Different Types Active Pharmaceutical Ingredient Product Interview Price
Table Global 2016 - 2021E Active Pharmaceutical Ingredient Sales (K MT) by Application
Table Different Application Active Pharmaceutical Ingredient Product Interview Price
Table Teva Information List
Table Product A Overview
Table Product B Overview
Table 2020 Teva Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex - factory Price (USD/MT)
Figure 2020 Teva Active Pharmaceutical Ingredient Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2020 Novartis Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex - factory Price (USD/MT)
Figure 2020 Novartis Active Pharmaceutical Ingredient Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2015 Pfizer Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex - factory Price (USD/MT)
Figure 2020 Pfizer Active Pharmaceutical Ingredient Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2020 Johnson & Johnson Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex - factory Price (USD/MT)
Figure 2020 Johnson & Johnson Active Pharmaceutical Ingredient Business Region Distribution
Table Mylan Information List
Table Product A Overview
Table Product B Overview
Table 2020 Mylan Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex - factory Price (USD/MT)
Figure 2020 Mylan Active Pharmaceutical Ingredient Business Region Distribution
Table North China Pharmaceutical Group Information List
Table Product A Overview
Table Product B Overview
Table 2020 North China Pharmaceutical Group Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex - factory Price (USD/MT)
Figure 2020 North China Pharmaceutical Group Active Pharmaceutical Ingredient Business Region Distribution
Table Dr. Reddys Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2020 Dr. Reddys Laboratories A
